[Congressional Record Volume 146, Number 10 (Tuesday, February 8, 2000)]
[House]
[Page H224]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
SUPPORT H. RES. 414 FOR STEM CELL MEDICAL RESEARCH
The SPEAKER pro tempore. Under the Speaker's announced policy of
January 19, 1999, the gentlewoman from Maryland (Ms. Morella) is
recognized during morning hour debates for 5 minutes.
Mrs. MORELLA. Mr. Speaker, last week I joined with my good friend and
colleague, the gentlewoman from New York (Mrs. Maloney), in the
introduction of H. Res. 414 to allow Federal funding of pluripotent
stem cell research to help us further understand Parkinson's, cancer,
blindness, AIDS, Alzheimer's, diabetes, Muscular Dystrophy, Sickle-Cell
Anemia, brain and spinal cord injuries, heart, lung, kidney and liver
diseases, strokes, Lou Gehrig's Disease, birth defects, and other life-
threatening diseases and disabilities.
House Resolution 414 does not request a specific amount of money, nor
does it direct disease-specific research. It simply asks that Federal
money be allowed to be utilized for the next best chance science has,
not only to treat, but to cure, debilitating and life-threatening
illnesses that afflict millions of Americans.
Many people have confused pluripotent stem cell research with human
embryo research. Stem cells are not embryos. In fact, there is a ban on
the use of Federal funds for human embryo research in the United
States. Pluripotent stem cells cannot develop into complete human
beings; and, therefore, under the law, they are not embryos.
Pluripotent stem cells are the type of cell that can be turned into
almost any type of cell or tissue in the body. The medical community
estimates that human pluripotent stem cell research makes it a very
real possibility that Parkinson's Disease will be cured within 5 years.
The American Cancer Society strongly supports pluripotent stem
research. In fact, cancer research has shown that injections of stem
cells could revive the immune response of patients undergoing bone
marrow transplants. With stem cell technology, transplantation of human
retinal tissue may be the cure for blinding retinal degenerative
diseases which affect more than 6 million Americans.
Stem cell research holds the key; it holds the key to solve the
problem of the body's reaction to foreign tissue, resulting in dramatic
improvements in the treatment of a number of life-threatening
conditions such as burns and kidney failure for which transplantation
is currently used.
While the potential medical benefits of pluripotent stem cell
technology are unprecedented, the National Institutes of Health has
proposed guidelines outlining that this area of research must be
conducted in accordance with strict ethical standards.
{time} 1300
NIH understands the ethical, legal, and social issues relevant to
human pluripotent stem cell research and is sensitive to the need to
subject it to oversight that is more stringent than that associated
with the traditional NIH scientific peer review process.
Most importantly, Mr. Speaker, Federal funding would bring with it a
level of oversight that will not be present if the work remains the
sole province of the private sector.
Finally, the American people support stem cell research, as shown by
a nationwide survey conducted by Opinion Research Corporation
International last year. They found that 74 percent of those polled
favored funding of stem cell research by NIH.
Federal funds are crucial to allow scientists to proceed with stem
cell research, which offers hope to more than 100 million Americans who
suffer from a myriad of deadly and debilitating diseases.
In closing, Mr. Speaker, I want to urge my colleagues to support
medical research in the search to find the cure for life-threatening
disease and disability. I ask them to cosponsor House Resolution 414.
____________________